Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Insights are not available.
Coherent Market Insights
Pulmonary Arterial Hypertension (PAH) Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Pulmonary hypertension or PH is a condition in which the blood pressure rises in the pulmonary artery, vein, or capillaries (collectively known as lung vasculature), which might lead to shortness of breath, fainting, leg swelling, and dizziness, among others. Pulmonar

Coherent Market Insights
Opioid Induced Constipation Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Opioids are medications that work on opioid receptors in order to generate morphine-like effects. These are mainly used therapeutically to relieve pain and are often abused by individuals addicted to them. Opioids comprises opiates, a conventional name that points to

Coherent Market Insights
Viscosupplementation Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Viscosupplementation is a treatment that helps reduce the joint pain and improves the functional condition of the osteoarthritic joint. It involves the injection of a thick fluid called hyaluronate into the knee. Hyaluronic acid is found in the viscous synovial fluid

Coherent Market Insights
Gastric Cancer Therapeutics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Gastric cancer, also known as stomach cancer, is a type of cancer that develops within the inside layer of the stomach. Symptoms may include upper abdominal pain, yellowing of the skin, heartburn, sudden weight loss, blood in the stool, loss of appetite, and nausea, a

Coherent Market Insights
Venous Thromboembolism (VTE) Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

According to the International Society on Thrombosis and Hemostasis, Inc., venous thromboembolism (VTE) is a leading cause of death and disability worldwide. Approximately 10 million cases of venous thromboembolism occur annually. VTE refers to the formation of blood

Coherent Market Insights
Immune Check Activators Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Immuno-stimulators are chemical compounds that can be drugs or nutrient substitutes that induce resistance in the human body by encouraging stimulation or increasing activity of any of its mechanisms. Immune-stimulants are broadly classified into specific immune-stimu

Coherent Market Insights
PD-1 and PDL-1 Inhibitors Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Targeted cancer therapy is the primary objective of extensive research related to cancer drugs. Our immune cells are programmed to attack the foreign cell on activation. PD-1 and PDL-1 are among those activation points present on the immune cells. Sometimes cancer cells also use this PD-1 and PDL

Coherent Market Insights
Short Bowel Syndrome Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Short bowel syndrome (SBS) is a malabsorption syndrome caused as a result of the small intestine not functioning efficiently. One of the prime symptoms of short bowel syndrome is diarrhea, which leads to dehydration, malnutrition, and unexplained and drastic weight lo

Coherent Market Insights
Celiac Disease Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Celiac disease is an autoimmune disorder that mainly affects the small intestine. It is mainly observed in individual who are hereditarily inclined towards gluten. Celiac disease symptoms include gastrointestinal malfunction such as diarrhea, abdominal distention, los

Coherent Market Insights
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and

Coherent Market Insights
Rheumatoid Arthritis Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheuma

Coherent Market Insights
Ovarian Cancer Drugs Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Ovarian cancer is one of the most dreadful type of cancer widely found in women. In this cancer, abnormal cells growth is experienced in the ovaries, which has potential to invade or adversely affect other body parts such as abdomen layers, lining of the bowel and bla

Coherent Market Insights
Regenerative Medicine Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Regenerative medicines are medical products or active pharmaceutical ingredients that have the ability to cure or replace organs and tissues organs damaged by various factors such as aging, diseases, trauma, and can also be used to provide stability in congenital diso

Coherent Market Insights
Sickle Cell Anemia Therapeutics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

A drastic reduction in the total red blood cells or RBC count or hemoglobin is known as anemia. It can be defined as the inability to carry optimum amount of oxygen by the blood. Sickle-cell diseases (SCD) are types of blood disorders which are usu

Coherent Market Insights
Rehabilitation Products Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Rehabilitation involves personalized healthcare used for to maintaining, improving, or restoring health conditions. In the conventional sense, rehabilitation assists a person achieve greater control of their own health after injury, surgery, or illness. It can also be

Coherent Market Insights
Postoperative Pain Management Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Postoperative pain includes all type of acute pain that occurs due to injuries and can resolve in appropriate healing period. Such pain often responds to analgesic medication and treatment of the precipitating cause. Postoperative pain can also cause cardiovascular, r

Coherent Market Insights
Burkholderia Infections Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

Burkholderia infections are caused by Burkholderia cepacia. It is a gram negative bacillus found in aquatic environment. It is a low virulent bacteria and is a frequent colonizer of fluids used in the hospitals such as IV fluid, irrigation solution etc. B

Coherent Market Insights
Vasculitis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2019

A group of disorder caused by the inflammation of blood vessels is known as vasculitis (plural: vasculitides), also called angiitis. Vasculitis includes inflammation of arteries, veins, and/or capillaries. The disease can affect both males and females equally without

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.